ReviewTherapeutics and clinical risk management2021

Ocrelizumab for the Treatment of Multiple Sclerosis: Safety, Efficacy, and Pharmacology.

Chiara Rosa Mancinelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.